Press Releases

Haemonetics 1st Quarter Fiscal Year 2023 Earnings Release Available on Investor Relations Website

Financial release accessible online

BOSTON, Aug. 10, 2022 /PRNewswire/ — Haemonetics Corporation (NYSE: HAE) announced that financial results for its first quarter fiscal 2023, which ended July 2, 2022, are available on its Investor Relations website.

The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. EDT on August 10, 2022. The conference call and webcast can be accessed with the following information:

In addition, the Company has posted to its Investor Relations website the earnings release and analytical tables and supplemental information that will be referenced on its conference call and webcast, direct links to which are available below.

Direct link to 1Q FY23 Earnings Release

https://haemonetics.gcs-web.com/static-files/28d85dc8-1d09-4355-937b-0cc17f6d51a5

Direct link to 1Q FY23 Analytical Tables and Supplemental Information:

https://haemonetics.gcs-web.com/static-files/4abb751e-3eb6-41a8-a06b-b3c48ba9d5c9

A replay of the conference call and webcast will be available for one year beginning on August 10, 2022, at 11:00 a.m. EDT using the conference call webcast link provided in this press release.

ABOUT HAEMONETICS

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contacts:


Olga Guyette, Sr. Director-Investor Relations & Treasury

David Trenk, Manager-Investor Relations

(781) 356-9763

(203) 733-4987

olga.guyette@haemonetics.com

david.trenk@haemonetics.com



Media Contact:


Josh Gitelson, Director-Global Communications


(781) 356-9776


josh.gitelson@haemonetics.com


 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-1st-quarter-fiscal-year-2023-earnings-release-available-on-investor-relations-website-301602928.html

SOURCE Haemonetics Corporation

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More
Videos